Ludwig-Maximilians-Universität München

München 81377

1 studies enrolling now · 4 studies all time

What they study most

Adenocarcinoma, Pancreatic Ductal, Facioscapulohumeral Muscular Dystrophy, Heart Failure, Multiple Sclerosis

Studies at this site

• A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC — Recruiting now
• Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD — Running, not enrolling
• Reducing Lung CongestIon Symptoms in Advanced Heart Failure — Running, not enrolling
• Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) — Stopped early